SUZHOU,China,March 18,2025-- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co.,Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibo
-Full Year 2024 Transaction Volume reached RMB206.2 billion,up 6.1% year-over-year- -Full Year 2024 International Transaction Volume exceeded RMB10.1 billion,up 27.8% year-over-year-
SHANGHAI,March 18,2025-- FinVolution Group (NYSE: FINV),a leading fintech company,today announced its unaudited financial results for 2024,highlighting continued global expansion,strategic collaborat
SHENZHEN,China,March 14,2025-- MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ:MLGO),today announcedthat their research and development team has improved the stability and pr
SHANGHAI,March 13,2025-- BioCity Biopharmaceutics Co.,Ltd.,a clinical-stage biopharmaceutical company,today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck
HONG KONG,March 13,2025-- The Global Sources Hong Kong Shows,scheduled for 11–30 April,2025,at the Hong KongAsiaWorld-Expo,will kick off the prime global sourcing season for the first half of 2025. T
